
Harvard Bioscience HBIO
$ 6.88
0.29%
Annual report 2025
added 03-13-2026
Harvard Bioscience EV - Enterprise Value 2011-2026 | HBIO
Annual EV - Enterprise Value Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.6 M | 79.7 M | 248 M | 178 M | 289 M | 251 M | 188 M | 200 M | 187 M | 129 M | 136 M | 194 M | 153 M | 117 M | 101 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 289 M | 78.6 M | 168 M |
EV - Enterprise Value of other stocks in the Medical instruments industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
7.99 B | $ 76.58 | 1.05 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
36 M | $ 11.19 | 1.85 % | $ 27.1 M | ||
|
The Cooper Companies
COO
|
20.4 B | $ 64.76 | 0.52 % | $ 12.9 B | ||
|
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | ||
|
iRhythm Technologies
IRTC
|
5.71 B | $ 125.16 | 2.3 % | $ 4.01 B | ||
|
Repro Med Systems
KRMD
|
201 M | $ 3.94 | -0.51 % | $ 182 M | ||
|
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | ||
|
Milestone Scientific
MLSS
|
27.7 M | $ 0.31 | -2.41 % | $ 25.4 M | ||
|
Haemonetics Corporation
HAE
|
2.76 B | $ 59.95 | -0.05 % | $ 3.02 B | ||
|
electroCore
ECOR
|
13.4 M | $ 6.1 | -1.21 % | $ 51.7 K | ||
|
ICU Medical
ICUI
|
3.36 B | $ 121.97 | -2.29 % | $ 3.01 B | ||
|
Microbot Medical
MBOT
|
120 M | $ 2.21 | 0.45 % | $ 101 M | ||
|
Envista Holdings Corporation
NVST
|
3.62 B | $ 27.04 | 0.93 % | $ 4.54 B | ||
|
Isoray
ISR
|
29.3 M | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
170 B | $ 482.7 | 0.1 % | $ 172 B | ||
|
Glaukos Corporation
GKOS
|
4.69 B | $ 123.75 | 1.72 % | $ 5.99 B | ||
|
STERIS plc
STE
|
27.5 B | $ 221.43 | -0.17 % | $ 21.8 B | ||
|
Masimo Corporation
MASI
|
10.4 B | $ 178.55 | -0.04 % | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
197 M | $ 10.83 | 4.94 % | $ 224 M | ||
|
Teleflex Incorporated
TFX
|
8.89 B | $ 137.51 | 0.7 % | $ 6.14 B | ||
|
Merit Medical Systems
MMSI
|
5.51 B | $ 68.43 | -0.22 % | $ 4.05 B | ||
|
Utah Medical Products
UTMD
|
117 M | $ 68.25 | 1.61 % | $ 221 M | ||
|
Pulse Biosciences
PLSE
|
1.64 B | $ 23.51 | 2.11 % | $ 1.58 B | ||
|
West Pharmaceutical Services
WST
|
17.9 B | $ 308.57 | 0.88 % | $ 22.3 B | ||
|
DENTSPLY SIRONA
XRAY
|
6.29 B | $ 11.98 | 0.67 % | $ 2.39 B | ||
|
Retractable Technologies
RVP
|
85.7 M | $ 0.65 | 1.41 % | $ 19.5 M | ||
|
Pro-Dex
PDEX
|
175 M | $ 52.07 | -0.06 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
2.73 B | $ 114.44 | 0.87 % | $ 2.59 B | ||
|
Predictive Oncology
POAI
|
-5.62 M | - | - | $ 31.1 M | ||
|
STAAR Surgical Company
STAA
|
895 M | $ 26.27 | 2.34 % | $ 1.3 B | ||
|
BioLife Solutions
BLFS
|
1.09 B | $ 21.82 | 2.06 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
191 M | $ 1.92 | -0.78 % | $ 175 M | ||
|
Baxter International
BAX
|
21.6 B | $ 18.38 | 1.24 % | $ 9.43 B | ||
|
ResMed
RMD
|
36.5 B | $ 221.41 | 0.77 % | $ 32.3 B | ||
|
AtriCure
ATRC
|
1.55 B | $ 28.94 | -1.16 % | $ 1.38 B | ||
|
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
396 M | $ 11.26 | 1.4 % | $ 460 M | ||
|
Becton, Dickinson and Company
BDX
|
55.5 B | $ 153.02 | 0.59 % | $ 44 B | ||
|
Nephros
NEPH
|
21.7 M | $ 2.89 | 0.7 % | $ 30 M | ||
|
OraSure Technologies
OSUR
|
98.2 M | $ 3.01 | 0.33 % | $ 221 M | ||
|
Repligen Corporation
RGEN
|
126 M | $ 118.66 | 0.9 % | $ 6.61 M |